Results 1 to 10 of about 27,943 (232)

Antiphospholipid Antibodies and COVID‐19: A Systematic Review of Clinical Implications [PDF]

Immunity, Inflammation and Disease
Introduction As the COVID‐19 pandemic transitions, understanding the intricate dynamics of the disease becomes paramount. This systematic review explores the role of antiphospholipid antibodies in COVID‐19, focusing on their potential clinical ...
Tahereh Sabaghian, Amir Behnam Kharazmi, Fatemeh Omidi, Bahareh Hajikhani, Shabnam Tehrani, Sayna Mardani, Amir Hashem Shahidi Bonjar, Rosella Centis, Lia D'Ambrosio, Giovanni Sotgiu, Fabio Angeli, Mohammad Javad Nasiri, Giovanni Battista Migliori   +12 more
doaj   +2 more sources

Antiphospholipid antibodies and subclinical interstitial lung disease in the MESA cohort [PDF]

Respiratory Research
Background Interstitial lung disease (ILD) is a rare complication of antiphospholipid syndrome (APS), but circulating antiphospholipid antibodies have been detected in patients with ILD without APS. Whether antiphospholipid antibodies are associated with
Claire F. McGroder, Mary M. Salvatore, John Newell, Jubal Watts, P. Hrudaya Nath, Sushilkumar K. Sonavane, Eric A. Hoffman, Ganesh Raghu, R. Graham Barr, John S. Kim, Anna J. Podolanczuk, Christine Kim Garcia, Elana J. Bernstein   +12 more
doaj   +2 more sources

Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus [PDF]

Biomedicines
In systemic lupus erythematosus (SLE), cardiovascular complications are among the leading causes of death. Cardiovascular risk in SLE is even higher in the presence of antiphospholipid antibodies or secondary antiphospholipid syndrome (APS).
Nikolett Nagy, Bernadett Bói, Gábor Papp, Edit Fiák, Eszter Gáspár-Kiss, Bianka Perge, Nikolett Farmasi, Tünde Tarr   +7 more
doaj   +2 more sources

Antiphospholipid antibody testing

Medicina Clínica
Antiphospholipid antibodies (aPL) are a family of autoantibodies targeting phospholipid-binding proteins and are associated with several clinical settings, and most notably define the antiphospholipid syndrome (APS). These antibodies can be identified using a variety of laboratory tests, which include both solid-phase immunological assays and ...
Savino Sciascia, Barbara Montaruli, María Infantino   +2 more
openalex   +3 more sources

Cardiovascular Risk Factors and Antiphospholipid Antibodies in Giant Cell Arteritis-Related Thrombosis. [PDF]

Arch Rheumatol
El Hasbani G, Crowson C, Snyder M, Warrington K, Koster M.   +4 more
europepmc   +3 more sources

Prevalence of Antiphospholipid Antibodies among Critically Ill Obstetric Patients with Bad Obstetric History Admitted to Intensive Care Unit of a Tertiary Care Centre [PDF]

Indian J Crit Care Med
Pattanayak T, Ahmed A, Prasad D.
europepmc   +2 more sources

Pediatric antiphospholipid syndrome [PDF]

Medicinski Podmladak, 2023
Antiphospholipid syndrome is a multisystemic autoimmune disease characterized by the appearance of arterial and/or venous thrombosis, often in multiple locations, thrombocytopenia and repeated spontaneous abortions in affected pregnant women, due to the ...
Petrović Gordana, Pašić Srđan
doaj   +1 more source

Consequences of antiphospholipid syndrome in pregnancy - A review [PDF]

Romanian Journal of Rheumatology, 2023
Background and objectives. Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies (aPL) in the blood.
Astrit M. Gash
doaj   +1 more source

Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection

Journal of Investigative Medicine High Impact Case Reports, 2023
COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome.
Lauren Bitterman MD, Mahdis Solhjoo MD, Vivek Shah MD, Sue Min Kwon MD, Karina Torralba MD, Hana Kazbour MD   +5 more
doaj   +1 more source

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy

BMC Nephrology, 2020
Background The kidney is a major target in primary antiphospholipid syndrome. Several types of nephropathy have been reported, the most frequent being acute or chronic specific vascular nephropathies and membranous nephropathy.
Maxime Teisseyre, Hélène Perrochia, Pascal Reboul, Sylvain Cariou, Sophie Renaud, Cédric Aglae, Olivier Moranne   +6 more
doaj   +1 more source